You have read all your free articles, to continue reading subscribe to read the rest of this content.
The two companies will partner to develop next-generation respiratory inhalers using the propellant HFO-1234ze. HFO-1234ze has up to 99.9% less Global Warming Potential (GWP) than propellants currently used in respiratory medicines, states AstraZeneca. "We are making great progress on our ambiAlready a subscriber Login You have read all your free…
Recipharm announces that it will continue the manufacturing operations at its facility in Höganäs, Sweden, operations that earlier were set towards being discontinued. In 2017, Recipharm announced the intention to discontinue the operations in Höganäs and evaluate different options for the faAlready a subscriber Login You have read all your…
Fermion Oy, which manufactures active pharmaceutical ingredients (APIs) for the global market, has entered the commissioning phase of its new plant in Hanko. The new manufacturing facility will replace the company's oldest manufacturing unit. At the same time, it will ensure Fermion's preparednesAlready a subscriber Login You have read all…
NeuroVive Pharmaceutical has signed a preclinical collaboration agreement with the Children's Hospital of Philadelphia (CHOP) and Marni J. Falk, M.D., a US opinion leader in the mitochondrial medicine field. Dr. Falk's research team at CHOP will evaluate compounds from NeuroVive's research prograAlready a subscriber Login You have read all your…
